EW
Edwards Lifesciences Corporation
Price Chart
Latest Quote
$86.27
-1.09 (-1.25%)
Current Price
| Previous Close | $87.36 |
| Open | $87.34 |
| Day High | $87.41 |
| Day Low | $85.75 |
| Volume | 926,895 |
Stock Information
| Shares Outstanding | 575.80M |
| Total Debt | $702.90M |
| Cash Equivalents | $3.67B |
| Revenue | $6.30B |
| Net Income | $1.08B |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $49.67B |
| P/E Ratio | 46.63 |
| EPS (TTM) | $1.85 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $47.33B |
| Sales | $6.30B |
| Income | $1.08B |
| Book/sh | $17.90 |
| Cash/sh | $6.38 |
| Employees | 16K |
Financial Ratios
| Quick Ratio | 3.30 |
| Current Ratio | 4.42 |
| Debt/Eq | 6.81 |
| EPS Growth TTM | 6.30% |
Returns & Margins
| ROA | 8.27% |
| ROE | 10.46% |
| Gross Margin | 77.87% |
| Operating Margin | 31.22% |
| Profit Margin | 17.39% |
Ownership
| Insider Ownership | 0.18% |
| Institutional Ownership | 94.12% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 25.62 |
| PEG | 2.10 |
| P/S | 7.88 |
| P/B | 4.82 |
Analyst Data
| Recommendation | buy |
| Target Price | $96.92 |
Technical Indicators
| SMA20 | $86.65 |
| SMA50 | $83.40 |
| SMA200 | $81.99 |
| RSI | 44.26 |
| ATR | 2.4271 |
| Shares Float | 573.99M |
| Short Float | 2.40% |
| Short Ratio | 2.48 |
| Volatility | 0.87 |
| Rel Volume | 0.18 |
Performance History
| Week | +1.36% |
| Month | +3.98% |
| Quarter | +4.57% |
| 6 Months | +1.69% |
| YTD | +1.10% |
| Year | +16.61% |
| 3 Years | -4.71% |
| 5 Years | -14.55% |
| 10 Years | +163.98% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $86.27 | 926,895 |
| 2026-06-18 | $87.36 | 5,550,200 |
| 2026-06-17 | $86.68 | 5,030,000 |
| 2026-06-16 | $88.58 | 5,638,100 |
| 2026-06-15 | $86.28 | 2,929,800 |
| 2026-06-12 | $85.11 | 4,571,600 |
| 2026-06-11 | $85.76 | 5,087,000 |
| 2026-06-10 | $85.98 | 4,537,900 |
| 2026-06-09 | $87.54 | 3,442,500 |
| 2026-06-08 | $85.85 | 4,374,200 |
| 2026-06-05 | $85.96 | 5,779,000 |
| 2026-06-04 | $87.45 | 4,530,600 |
| 2026-06-03 | $86.00 | 4,971,500 |
| 2026-06-02 | $87.66 | 6,186,800 |
| 2026-06-01 | $88.16 | 7,649,500 |
| 2026-05-29 | $86.47 | 7,270,600 |
| 2026-05-28 | $85.96 | 6,438,800 |
| 2026-05-27 | $86.51 | 7,328,200 |
| 2026-05-26 | $87.54 | 5,116,100 |
| 2026-05-22 | $85.78 | 4,941,700 |
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
đ° Latest News
Here's How Macro Trends and Currency Headwind Restrict GMED's Growth
Zacks âĸ 2026-06-22T14:28:00Z
Stocks Indexes Finish Mostly Lower as Chipmakers Retreat
Barchart âĸ 2026-06-16T20:33:56Z
Edwards Lifesciences Seen Benefiting From CMS Transcatheter Aortic Valve Replacement Rule, RBC Says
MT Newswires âĸ 2026-06-16T15:49:53ZBroader Market Weakens as Energy and Software Stocks Fall
Barchart âĸ 2026-06-16T15:15:38Z
Stocks Supported by Lower Crude Oil Prices and Bond Yields
Barchart âĸ 2026-06-16T14:18:10Z
SpaceX, Rackspace surge premarket; Edgewise Therapeutics, Huntsman fall
Investing.com âĸ 2026-06-16T12:44:12ZCMS proposes Medicare coverage expansion for TAVR
MedTech Dive âĸ 2026-06-16T11:05:16Z
Should You Continue to Hold EW Stock in Your Portfolio?
Zacks âĸ 2026-06-12T12:31:00Z
Possible Bearish Signals With Edwards Lifesciences Insiders Disposing Stock
Simply Wall St. âĸ 2026-06-05T14:00:06Z
Why Is Veracyte (VCYT) Up 18.2% Since Last Earnings Report?
Zacks âĸ 2026-06-04T15:30:29Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,334,200,000 | $1,117,500,000 | $978,400,000 | $723,700,000 |
| Cost Of Revenue | $1,334,200,000 | $1,117,500,000 | $978,400,000 | $723,700,000 |
| Total Revenue | $6,067,600,000 | $5,439,500,000 | $5,010,000,000 | $4,464,000,000 |
| Operating Revenue | $6,067,600,000 | $5,439,500,000 | $5,010,000,000 | $4,464,000,000 |
| Expenses | ||||
| Interest Expense | $20,400,000 | $19,800,000 | $17,600,000 | $19,200,000 |
| Total Expenses | $4,431,400,000 | $3,959,400,000 | $3,523,800,000 | $2,924,900,000 |
| Other Income Expense | $-511,700,000 | $-32,500,000 | $-163,400,000 | $-35,900,000 |
| Other Non Operating Income Expenses | $3,200,000 | $7,400,000 | $4,600,000 | $1,100,000 |
| Net Non Operating Interest Income Expense | $148,400,000 | $100,500,000 | $49,600,000 | $16,300,000 |
| Interest Expense Non Operating | $20,400,000 | $19,800,000 | $17,600,000 | $19,200,000 |
| Operating Expense | $3,097,200,000 | $2,841,900,000 | $2,545,400,000 | $2,201,200,000 |
| Other Operating Expenses | $-67,200,000 | $-300,000 | - | - |
| General And Administrative Expense | - | - | $1,823,400,000 | $1,566,500,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $1,060,100,000 | $1,400,900,000 | $1,223,000,000 | $1,324,000,000 |
| Net Interest Income | $148,400,000 | $100,500,000 | $49,600,000 | $16,300,000 |
| Interest Income | $168,800,000 | $120,300,000 | $67,200,000 | $35,500,000 |
| Normalized Income | $1,487,261,914 | $1,436,879,846 | $1,372,352,000 | $1,356,239,552 |
| Net Income From Continuing And Discontinued Operation | $1,073,500,000 | $4,174,600,000 | $1,402,400,000 | $1,521,900,000 |
| Total Operating Income As Reported | $1,264,200,000 | $1,378,700,000 | $1,308,900,000 | $1,498,400,000 |
| Net Income Common Stockholders | $1,073,500,000 | $4,174,600,000 | $1,402,400,000 | $1,521,900,000 |
| Net Income | $1,073,500,000 | $4,174,600,000 | $1,402,400,000 | $1,521,900,000 |
| Net Income Including Noncontrolling Interests | $1,069,400,000 | $4,169,700,000 | $1,399,400,000 | $1,521,900,000 |
| Net Income Discontinuous Operations | $13,400,000 | $2,773,700,000 | $179,400,000 | $197,900,000 |
| Net Income Continuous Operations | $1,056,000,000 | $1,396,000,000 | $1,220,000,000 | $1,324,000,000 |
| Pretax Income | $1,272,900,000 | $1,548,100,000 | $1,372,400,000 | $1,519,500,000 |
| Special Income Charges | $-518,900,000 | $-101,400,000 | $-177,300,000 | $-36,900,000 |
| Interest Income Non Operating | $168,800,000 | $120,300,000 | $67,200,000 | $35,500,000 |
| Operating Income | $1,636,200,000 | $1,480,100,000 | $1,486,200,000 | $1,539,100,000 |
| Gross Profit | $4,733,400,000 | $4,322,000,000 | $4,031,600,000 | $3,740,300,000 |
| Per Share | ||||
| Diluted EPS | $1.83 | $6.97 | $2.30 | $2.44 |
| Basic EPS | $1.84 | $6.98 | $2.31 | $2.46 |
| Other | ||||
| Tax Effect Of Unusual Items | $-87,738,086 | $-3,920,154 | $-18,648,000 | $-4,760,448 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,964,800,000 | $1,763,000,000 | $1,702,900,000 | $1,715,300,000 |
| Total Unusual Items | $-514,900,000 | $-39,900,000 | $-168,000,000 | $-37,000,000 |
| Total Unusual Items Excluding Goodwill | $-514,900,000 | $-39,900,000 | $-168,000,000 | $-37,000,000 |
| Reconciled Depreciation | $156,600,000 | $155,200,000 | $144,900,000 | $139,600,000 |
| EBITDA (Bullshit earnings) | $1,449,900,000 | $1,723,100,000 | $1,534,900,000 | $1,678,300,000 |
| EBIT | $1,293,300,000 | $1,567,900,000 | $1,390,000,000 | $1,538,700,000 |
| Diluted Average Shares | $585,800,000 | $599,300,000 | $609,400,000 | $624,200,000 |
| Basic Average Shares | $584,800,000 | $597,700,000 | $606,700,000 | $619,000,000 |
| Diluted NI Availto Com Stockholders | $1,073,500,000 | $4,174,600,000 | $1,402,400,000 | $1,521,900,000 |
| Minority Interests | $4,100,000 | $4,900,000 | $3,000,000 | $0 |
| Tax Provision | $216,900,000 | $152,100,000 | $152,400,000 | $195,500,000 |
| Other Special Charges | $325,400,000 | $40,400,000 | $203,500,000 | $12,000,000 |
| Write Off | $146,900,000 | $0 | $0 | - |
| Impairment Of Capital Assets | $40,000,000 | $0 | $0 | - |
| Restructuring And Mergern Acquisition | $6,600,000 | $61,000,000 | $-26,200,000 | $24,900,000 |
| Gain On Sale Of Security | $4,000,000 | $61,500,000 | $9,300,000 | $-100,000 |
| Research And Development | $1,079,200,000 | $1,053,000,000 | $962,900,000 | $843,600,000 |
| Selling General And Administration | $2,085,200,000 | $1,789,200,000 | $1,582,500,000 | $1,357,600,000 |
| Gain On Sale Of Business | - | - | $-17,200,000 | $-60,700,000 |
| Other Gand A | - | - | $1,824,600,000 | $1,567,600,000 |
| Salaries And Wages | - | - | $-1,200,000 | $-1,100,000 |
Fetched: 2026-06-14
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $7,440,800,000 | $7,045,100,000 | $5,105,500,000 | $4,357,200,000 |
| Total Assets | $13,697,200,000 | $13,055,300,000 | $9,363,200,000 | $8,292,500,000 |
| Total Non Current Assets | $6,958,300,000 | $6,769,900,000 | $5,327,500,000 | $5,196,700,000 |
| Other Non Current Assets | $142,600,000 | $172,900,000 | $774,300,000 | $299,100,000 |
| Non Current Prepaid Assets | $93,300,000 | $101,600,000 | - | - |
| Non Current Deferred Assets | $1,138,100,000 | $992,100,000 | $749,400,000 | $484,000,000 |
| Non Current Deferred Taxes Assets | $1,138,100,000 | $992,100,000 | $749,400,000 | $484,000,000 |
| Non Current Note Receivables | $173,700,000 | $129,300,000 | - | - |
| Non Current Accounts Receivable | $314,800,000 | $293,900,000 | - | - |
| Financial Assets | $5,800,000 | $34,700,000 | - | - |
| Investmentin Financial Assets | $243,900,000 | - | - | - |
| Goodwill And Other Intangible Assets | $2,896,800,000 | $2,953,300,000 | $1,544,500,000 | $1,449,500,000 |
| Other Intangible Assets | $1,128,200,000 | $1,176,600,000 | $399,400,000 | $285,200,000 |
| Current Assets | $6,738,900,000 | $6,285,400,000 | $4,035,700,000 | $3,095,800,000 |
| Other Current Assets | $339,300,000 | $347,600,000 | $224,900,000 | $195,900,000 |
| Assets Held For Sale Current | $0 | $26,800,000 | $317,600,000 | - |
| Prepaid Assets | $135,000,000 | $121,000,000 | $128,800,000 | $110,000,000 |
| Inventory | $1,126,200,000 | $1,086,700,000 | $903,500,000 | $875,500,000 |
| Receivables | $912,100,000 | $727,400,000 | $828,100,000 | $699,100,000 |
| Other Receivables | $252,500,000 | $118,300,000 | $56,600,000 | $56,100,000 |
| Accounts Receivable | $659,600,000 | $609,100,000 | $771,500,000 | $643,000,000 |
| Allowance For Doubtful Accounts Receivable | $-15,000,000 | $-11,600,000 | $-8,200,000 | $-7,900,000 |
| Gross Accounts Receivable | $674,600,000 | $620,700,000 | $779,700,000 | $650,900,000 |
| Cash Cash Equivalents And Short Term Investments | $4,226,300,000 | $3,975,900,000 | $1,632,800,000 | $1,215,300,000 |
| Cash And Cash Equivalents | $2,938,000,000 | $3,045,200,000 | $1,132,300,000 | $769,000,000 |
| Debt | ||||
| Total Debt | $705,400,000 | $700,000,000 | $685,100,000 | $691,300,000 |
| Long Term Debt And Capital Lease Obligation | $680,900,000 | $676,600,000 | $662,200,000 | $665,800,000 |
| Long Term Debt | $598,300,000 | $597,700,000 | $597,000,000 | $596,300,000 |
| Current Debt And Capital Lease Obligation | $24,500,000 | $23,400,000 | $22,900,000 | $25,500,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,359,600,000 | $2,992,400,000 | $2,643,800,000 | $2,485,800,000 |
| Total Non Current Liabilities Net Minority Interest | $1,545,900,000 | $1,487,200,000 | $1,448,400,000 | $1,463,400,000 |
| Other Non Current Liabilities | $865,000,000 | $757,900,000 | $586,300,000 | $511,200,000 |
| Current Liabilities | $1,813,700,000 | $1,505,200,000 | $1,195,400,000 | $1,022,400,000 |
| Other Current Liabilities | $25,300,000 | $10,300,000 | $144,700,000 | $20,700,000 |
| Current Deferred Liabilities | $27,200,000 | $53,700,000 | $0 | - |
| Payables And Accrued Expenses | $1,219,200,000 | $985,400,000 | $642,300,000 | $691,900,000 |
| Payables | $504,900,000 | $572,100,000 | $293,100,000 | $298,100,000 |
| Total Tax Payable | $277,400,000 | $374,700,000 | $106,500,000 | $96,200,000 |
| Accounts Payable | $227,500,000 | $197,400,000 | $186,600,000 | $201,900,000 |
| Liabilities Heldfor Sale Non Current | - | $0 | $25,100,000 | - |
| Tradeand Other Payables Non Current | - | $1,300,000 | $80,600,000 | $143,400,000 |
| Equity | ||||
| Total Equity Gross Minority Interest | $10,337,600,000 | $10,062,900,000 | $6,719,400,000 | $5,806,700,000 |
| Stockholders Equity | $10,337,600,000 | $9,998,400,000 | $6,650,000,000 | $5,806,700,000 |
| Gains Losses Not Affecting Retained Earnings | $-238,300,000 | $-244,500,000 | $-242,800,000 | $-254,900,000 |
| Other Equity Adjustments | $-238,300,000 | $-244,500,000 | $-242,800,000 | $-254,900,000 |
| Retained Earnings | $14,240,500,000 | $13,167,000,000 | $8,992,400,000 | $7,590,000,000 |
| Long Term Equity Investment | $34,700,000 | - | - | - |
| Other | ||||
| Treasury Shares Number | $78,000,000 | $66,200,000 | $49,400,000 | $38,000,000 |
| Ordinary Shares Number | $580,700,000 | $588,600,000 | $601,100,000 | $608,300,000 |
| Share Issued | $658,700,000 | $654,800,000 | $650,500,000 | $646,300,000 |
| Tangible Book Value | $7,440,800,000 | $7,045,100,000 | $5,105,500,000 | $4,357,200,000 |
| Invested Capital | $10,935,900,000 | $10,596,100,000 | $7,247,000,000 | $6,403,000,000 |
| Working Capital | $4,925,200,000 | $4,780,200,000 | $2,840,300,000 | $2,073,400,000 |
| Capital Lease Obligations | $107,100,000 | $102,300,000 | $88,100,000 | $95,000,000 |
| Total Capitalization | $10,935,900,000 | $10,596,100,000 | $7,247,000,000 | $6,403,000,000 |
| Minority Interest | $0 | $64,500,000 | $69,400,000 | $0 |
| Treasury Stock | $7,091,700,000 | $6,192,300,000 | $5,024,500,000 | $4,144,000,000 |
| Additional Paid In Capital | $2,768,400,000 | $2,613,400,000 | $2,274,400,000 | $1,969,300,000 |
| Capital Stock | $658,700,000 | $654,800,000 | $650,500,000 | $646,300,000 |
| Common Stock | $658,700,000 | $654,800,000 | $650,500,000 | $646,300,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Accrued Expenses | $0 | $52,700,000 | $94,200,000 | $143,000,000 |
| Long Term Capital Lease Obligation | $82,600,000 | $78,900,000 | $65,200,000 | $69,500,000 |
| Current Deferred Revenue | $27,200,000 | $53,700,000 | $0 | - |
| Current Capital Lease Obligation | $24,500,000 | $23,400,000 | $22,900,000 | $25,500,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $467,500,000 | $358,600,000 | $316,400,000 | $268,700,000 |
| Current Provisions | $50,000,000 | $73,800,000 | $69,100,000 | $15,600,000 |
| Current Accrued Expenses | $714,300,000 | $413,300,000 | $349,200,000 | $393,800,000 |
| Investments And Advances | $278,600,000 | $307,900,000 | $583,900,000 | $1,239,000,000 |
| Available For Sale Securities | $243,900,000 | - | - | - |
| Goodwill | $1,768,600,000 | $1,776,700,000 | $1,145,100,000 | $1,164,300,000 |
| Net PPE | $1,914,600,000 | $1,784,200,000 | $1,675,400,000 | $1,725,100,000 |
| Accumulated Depreciation | $-849,800,000 | $-794,500,000 | $-698,600,000 | $-750,400,000 |
| Gross PPE | $2,764,400,000 | $2,578,700,000 | $2,374,000,000 | $2,475,500,000 |
| Construction In Progress | $301,200,000 | $244,000,000 | $292,500,000 | $255,200,000 |
| Other Properties | $102,700,000 | $98,200,000 | $84,400,000 | $129,700,000 |
| Machinery Furniture Equipment | $814,800,000 | $772,800,000 | $695,700,000 | $785,100,000 |
| Buildings And Improvements | $1,393,300,000 | $1,339,800,000 | $1,189,000,000 | $1,189,200,000 |
| Land And Improvements | $152,400,000 | $123,900,000 | $112,400,000 | $116,300,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $676,700,000 | $609,400,000 | $511,400,000 | $541,700,000 |
| Work In Process | $252,900,000 | $236,200,000 | $195,800,000 | $177,400,000 |
| Raw Materials | $196,600,000 | $241,100,000 | $196,300,000 | $156,400,000 |
| Other Short Term Investments | $1,288,300,000 | $930,700,000 | $500,500,000 | $446,300,000 |
Fetched: 2026-06-14
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,335,000,000 | $259,900,000 | $629,500,000 | $953,400,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,595,200,000 | $542,300,000 | $895,800,000 | $1,218,200,000 |
| Cash Flow From Continuing Operating Activities | $1,595,200,000 | $542,300,000 | $895,800,000 | $1,218,200,000 |
| Operating Gains Losses | - | $-5,200,000 | $100,000 | $51,500,000 |
| Investing Activities | ||||
| Capital Expenditure | $-260,200,000 | $-282,400,000 | $-266,300,000 | $-264,800,000 |
| Investing Cash Flow | $-712,900,000 | $2,312,900,000 | $173,800,000 | $252,300,000 |
| Cash Flow From Continuing Investing Activities | $-712,900,000 | $2,312,900,000 | $173,800,000 | $252,300,000 |
| Net Other Investing Changes | $-69,500,000 | $-75,600,000 | $-59,200,000 | $-63,100,000 |
| Capital Expenditure Reported | $-260,200,000 | $-252,400,000 | $-253,000,000 | $-244,600,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-893,400,000 | $-1,159,400,000 | $-879,600,000 | $-1,727,100,000 |
| Financing Cash Flow | $-956,800,000 | $-983,000,000 | $-711,000,000 | $-1,584,500,000 |
| Cash Flow From Continuing Financing Activities | $-956,800,000 | $-983,000,000 | $-711,000,000 | $-1,584,500,000 |
| Net Other Financing Charges | $-237,500,000 | $-3,100,000 | $-1,300,000 | $-3,800,000 |
| Net Common Stock Issuance | $-893,400,000 | $-1,159,400,000 | $-879,600,000 | $-1,727,100,000 |
| Other | ||||
| End Cash Position | $2,939,500,000 | $3,058,800,000 | $1,148,000,000 | $772,600,000 |
| Beginning Cash Position | $3,058,800,000 | $1,148,000,000 | $772,600,000 | $867,400,000 |
| Effect Of Exchange Rate Changes | $-44,800,000 | $38,600,000 | $16,800,000 | $19,200,000 |
| Changes In Cash | $-74,500,000 | $1,872,200,000 | $358,600,000 | $-114,000,000 |
| Proceeds From Stock Option Exercised | $174,100,000 | $179,500,000 | $169,900,000 | $146,400,000 |
| Common Stock Payments | $-893,400,000 | $-1,159,400,000 | $-879,600,000 | $-1,727,100,000 |
| Net Investment Purchase And Sale | $-282,100,000 | $-134,400,000 | $610,300,000 | $580,200,000 |
| Sale Of Investment | $2,878,100,000 | $857,600,000 | $715,800,000 | $1,359,100,000 |
| Purchase Of Investment | $-3,160,200,000 | $-992,000,000 | $-105,500,000 | $-778,900,000 |
| Net Business Purchase And Sale | $-101,100,000 | $2,805,300,000 | $-111,000,000 | $0 |
| Purchase Of Business | $-101,100,000 | $-1,122,100,000 | $-111,000,000 | $0 |
| Net Intangibles Purchase And Sale | $0 | $-30,000,000 | $-13,300,000 | $-20,200,000 |
| Purchase Of Intangibles | $0 | $-30,000,000 | $-13,300,000 | $-20,200,000 |
| Change In Working Capital | $154,600,000 | $-259,300,000 | $-526,300,000 | $-421,400,000 |
| Change In Other Working Capital | $-176,300,000 | $-208,100,000 | $-17,400,000 | $-57,600,000 |
| Change In Payables And Accrued Expense | $318,600,000 | $52,700,000 | $113,000,000 | $-66,400,000 |
| Change In Accrued Expense | $-76,500,000 | $-36,800,000 | $-33,000,000 | $-45,000,000 |
| Change In Payable | $395,100,000 | $89,500,000 | $146,000,000 | $-21,400,000 |
| Change In Account Payable | $395,100,000 | $89,500,000 | $146,000,000 | $-21,400,000 |
| Change In Prepaid Assets | $-15,400,000 | $31,000,000 | $-191,700,000 | $100,000 |
| Change In Inventory | $50,700,000 | $-256,100,000 | $-289,000,000 | $-213,400,000 |
| Change In Receivables | $-23,000,000 | $121,200,000 | $-141,200,000 | $-84,100,000 |
| Other Non Cash Items | $-12,800,000 | $-3,362,200,000 | $10,500,000 | $-800,000 |
| Stock Based Compensation | $158,100,000 | $162,300,000 | $139,400,000 | $126,800,000 |
| Asset Impairment Charge | $186,900,000 | $0 | $0 | $55,100,000 |
| Deferred Tax | $-117,600,000 | $-323,400,000 | $-272,100,000 | $-254,500,000 |
| Deferred Income Tax | $-117,600,000 | $-323,400,000 | $-272,100,000 | $-254,500,000 |
| Depreciation Amortization Depletion | $156,600,000 | $155,200,000 | $144,900,000 | $139,600,000 |
| Depreciation And Amortization | $156,600,000 | $155,200,000 | $144,900,000 | $139,600,000 |
| Net Income From Continuing Operations | $1,069,400,000 | $4,169,700,000 | $1,399,400,000 | $1,521,900,000 |
| Interest Paid Supplemental Data | - | $19,600,000 | $19,900,000 | $19,300,000 |
| Income Tax Paid Supplemental Data | - | $1,196,100,000 | $470,100,000 | $504,100,000 |
| Sale Of Business | - | $3,927,400,000 | $0 | $0 |
| Gain Loss On Investment Securities | - | $-5,200,000 | $100,000 | $51,500,000 |
| Repayment Of Debt | - | - | $-300,000 | $-200,000 |
| Issuance Of Debt | - | - | $0 | $0 |
| Net Issuance Payments Of Debt | - | - | $-300,000 | $-200,000 |
| Net Long Term Debt Issuance | - | - | $-300,000 | $-200,000 |
| Long Term Debt Payments | - | - | $-300,000 | $-200,000 |
| Long Term Debt Issuance | - | - | $0 | $0 |
| Amortization Cash Flow | - | - | $6,100,000 | $5,700,000 |
| Amortization Of Intangibles | - | - | $6,100,000 | $5,700,000 |
| Depreciation | - | - | $138,900,000 | $133,900,000 |
Fetched: 2026-06-14